SEC Filing Summary: Capital Product Partners L.P. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed on November 14, 2023, by Capital Product Partners L.P. (CPLP), a foreign private issuer headquartered in Piraeus, Greece. The filing serves to report Unaudited Interim Condensed Consolidated Financial Statements for the nine-month periods ended September 30, 2023, and September 30, 2022. The filing incorporates by reference an Operating and Financial Review and Prospects discussion.
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit I and Exhibit II), which include:
- Unaudited Condensed Consolidated Balance Sheets as of September 30, 2023, and December 31, 2022.
- Unaudited Condensed Consolidated Statements of Comprehensive Income for the nine-month periods ended September 30, 2023, and 2022.
- Unaudited Condensed Consolidated Statements of Changes in Partners' Capital.
- Unaudited Condensed Consolidated Statements of Cash Flows.
As the source text does not provide a clear value for these figures, they cannot be summarized here.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Such analysis is located in the attached "Operating and Financial Review and Prospects" discussion referenced in Exhibit I.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the cover sheet text. This information is contained within the attached financial statements and the related Operating and Financial Review and Prospects discussion.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the Unaudited Condensed Consolidated Statements of Comprehensive Income (Exhibit II).
- Review the Unaudited Condensed Consolidated Statements of Cash Flows to assess liquidity and operating cash generation.
- Examine the Unaudited Condensed Consolidated Balance Sheets for changes in debt levels and working capital.
- Read the "Operating and Financial Review and Prospects" section in Exhibit I for management's explanation of performance variances and future outlook.
- Confirm the incorporation of these exhibits into the Registration Statement on Form F-3 (File No. 333-274680).